THE PATHOGENESIS OF HYPERACUTE XENOGRAFT REJECTION

被引:32
作者
STEVENS, RB
PLATT, JL
机构
[1] UNIV MINNESOTA,DEPT SURG,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455
[3] UNIV MINNESOTA,DEPT CELL BIOL & NEUROANAT,MINNEAPOLIS,MN 55455
关键词
TRANSPLANTATION; XENOTRANSPLANTATION; ENDOTHELIAL CELL; ENDOTHELIAL CELL ACTIVATION; HEPARAN SULFATE; COMPLEMENT;
D O I
10.1016/S0272-6386(12)70310-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A critical shortage of donor organs has driven many in the transplantation community to consider the use of animals as organ donors for humans, that is, xenotransplantation. While successful xenotransplantation of primate kidneys was achieved 25 years ago, most now advocate use of non primates as donors because of the risk of disease transmission and ethical concerns attendant to the use of primates. The major hurdle to xenotransplantation of organs between phylogenetically disparate species is the hyperacute rejection reaction that invariably destroys organ xenografts placed in unmodified recipients. Here we review recent insights concerning the pathogenesis of hyperacute rejection reactions. We focus particular attention on the endothelial cell, which serves not only as the target of xenoreactive antibodies and complement, but also, as a consequence of endothelial cell activation, as an instrument of tissue injury. We discuss a phenomenon called “accommodation” in which an organ graft acquires resistance to humoral-mediated injury. © 1992, National Kidney Foundation, Inc.. All rights reserved.
引用
收藏
页码:414 / 421
页数:8
相关论文
共 79 条
[11]  
BURDICK JF, 1979, J IMMUNOL, V123, P1732
[12]  
BUSCH GJ, 1975, AM J PATHOL, V79, P31
[13]  
CASALI P, 1989, ANNU REV IMMUNOL, V7, P513, DOI 10.1146/annurev.iy.07.040189.002501
[14]   CD5+ LYMPHOCYTE-B, POLYREACTIVE ANTIBODIES AND THE HUMAN B-CELL REPERTOIRE [J].
CASALI, P ;
NOTKINS, AL .
IMMUNOLOGY TODAY, 1989, 10 (11) :364-368
[15]  
CHARTRAND C, 1979, IMMUNOLOGY, V38, P245
[16]  
COLMAN RW, 1976, AM J PATHOL, V82, P25
[17]   INDUCTION AND DETECTION OF A HUMAN-ENDOTHELIAL ACTIVATION ANTIGEN INVIVO [J].
COTRAN, RS ;
GIMBRONE, MA ;
BEVILACQUA, MP ;
MENDRICK, DL ;
POBER, JS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (02) :661-666
[18]  
COTRAN RS, 1989, PROG IMMUNOL, V8, P747
[19]   INHIBITION OF COMPLEMENT-MEDIATED ENDOTHELIAL-CELL CYTOTOXICITY BY DECAY-ACCELERATING FACTOR - POTENTIAL FOR PREVENTION OF XENOGRAFT HYPERACUTE REJECTION [J].
DALMASSO, AP ;
VERCELLOTTI, GM ;
PLATT, JL ;
BACH, FH .
TRANSPLANTATION, 1991, 52 (03) :530-533
[20]   COMPLEMENT IN THE PATHOPHYSIOLOGY AND DIAGNOSIS OF HUMAN-DISEASES [J].
DALMASSO, AP .
CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1986, 24 (02) :123-183